BioMarin Pharmaceutical, Inc. (BMRN)
60.57
+0.14
(+0.23%)
USD |
NASDAQ |
Mar 05, 16:00
61.19
+0.62
(+1.02%)
Pre-Market: 08:19
BioMarin Pharmaceutical Cash from Investing (TTM) : -414.24M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Amicus Therapeutics, Inc. | -46.43M |
| Gilead Sciences, Inc. | -4.793B |
| Merck & Co., Inc. | -13.74B |
| MannKind Corp. | -304.80M |
| AbbVie, Inc. | -6.643B |